The pathogenesis of renal fibrosis in crescentic nephritis is incompletely understood. To improve our 
Introduction
Increased collagen accumulation with progressive renal scarring is the final common pathway to chronic renal failure in many renal diseases. Much has been learned recently about the pathogenesis of glomerular and interstitial fibrosis from the study of animal models (1) (2) (3) (4) (5) , human renal biopsies (6) , and cell culture systems (7) (8) (9) . However, less has been published regarding the time. course for development of renal fibrosis. It has been observed clinically. that therapy is less effective in preventing or delaying chronic renal failure once significant fibrosis is present (10) . Furthermore, the interaction between elements regulating fibrogenesis may be better understood by looking at the net effect on collagen synthesis and accumulation. The principal aim ofthis study was to examine histologically and biochemically the development of renal fibrosis in a rabbit model of crescentic nephritis.
From previous reports it appears that both interstitial (I and III) and basement membrane (IV and V) collagens consti-tute the fibrotic lesion in certain glomerular diseases (1, 5, 6) . Their distribution between the glomerulus and interstitium may be dependent on the integrity of Bowman's capsule (6) . Another aim of this study was to examine the pattern ofdistribution of interstitial and type IV collagens in this animal model.
Methods
Model of antiglomerular basement membrane disease. The method used to produce crescentic nephritis in rabbits has been previously described (1 1) . Briefly, New Zealand White rabbits, weighing 2.0-3.0 kg, were injected subcutaneously with 100 1Ag ofguinea pig IgG in CFA (Sigma Chemical Co., St. Louis, MO) and 5 d later they were given an intravenous injection of guinea pig anti-rabbit glomerular basement membrane (anti-GBM)' IgG. Control animals received no injections.
Rabbits were kept in individual cages and were given water and regular rabbit chow ad lib.
At the indicated times, renal tissue samples were obtained for analysis from these animals. Rabbits were sedated with 25-50 mg/kg, i.v. sodium pentobarbital. The kidneys were then perfused with normal saline until blanched (100 to 200 cm3), and then with 180 cm3 of iron oxide (2.5 mg/ml) in 1% BSA. The kidneys were then harvested, the capsule was removed, and the cortex was trimmed off with scissors. A piece of cortex was homogenized in 0.5 M acetic acid by polytron (Brinkmann Instruments Co., Westbury, NY), divided into three aliquots, dried in a speed vac concentrator (Savant Instruments, Inc., Hicksville, NY), and stored at -70'C. Sections for light microscopy were placed in 10% formalin, and sections for immunofluorescent analysis were frozen in liquid nitrogen and stored at -70'C. The remaining cortex was homogenized in chilled PBS by a Polytron (Brinkmah Instruments) and then passed sequentially through a brass screen, 25 openings per inch (Bel-Art Products, Pequannock, NJ), a nylon screen, 90-,gm opening diam (Tetko Inc., Elmsford, NY), and into a 250-ml beaker. The filtrate was then placed on a magnet and the iron-embolized glomeruli were purified by repeated washings with chilled PBS. Glomerular purity and yield were determined by lowpower (X 10) examination of 10-ul contamination by type III collagen as quantitated by SDS-PAGE with interrupted reduction (19) . No other contaminant was apparent by SDS-PAGE. A female goat was immunized subcutaneously with 10 mg (dry weight) of this collagen preparation in 1 cm3 CFA and was given three booster injections biweekly of 2 mg collagen in 1 cm3 CFA subcutaneously. 7 d after the final injection the goat was exsanguinated, and the serum was aliquoted and stored at -30'C. This immune serum is hereafter designated anti-I/III, and was absorbed with rabbit serum before use. Western blot analysis using the purified collagen and commercially available pure types I and III collagen (Sigma Chemical Co.) showed staining of predominantly type I collagen -bands, but also some type III staining.
Antiserum to type IV collagen. A female goat was immunized with 1 mg of purified human placenta type IV collagen (Sigma Chemical Co.) in 1 cm3 CFA subcutaneously for a total of seven doses at biweekly intervals. 7 d after each of the last two immunizations, 100-200 ml of blood was obtained by jugular vein puncture, the serum was pooled, aliquoted, and stored at -30'C. Western blot analysis of plasma-absorbed antibody showed staining of type IV human collagen. Affinity chromatography. In some studies anti-type I/III and antitype IV antibodies were immunopurified by passage of immune IgG fractions over Sepharose 4B columns to which type I/III or type IV collagen had been immobilized by cyanogen bromide activation (20) . Briefly, purified rabbit type I/III or human placental type IV (Sigma Chemical Co.) collagen were immobilized onto Sepharose 4B after cyanogen bromide activation (20) . After inactivation of unreacted sites, the beads were poured into a 1.0 X 10-cm column, and IgG fraction of anti-type I/III or anti-type IV antiserum were then applied. The columns were then eluted with at least two column volumes of PBS until no more 280 nm absorbing material was detected in the effluent. Specific antibodies were then eluted from the affinity column by glycine-HCl buffer, pH 2.0. No differences were observed in the immunofluorescent patterns using affinity-purified antibodies compared with unfractionated antiserum.
Immunofluorescence. Indirect fluorescence using goat anti-serum against interstitial (anti-I/III) or type IV collagens (anti-IV) diluted 1:100, or affinity-purified IgG, was done using fluorescein-labeled rabbit anti-goat IgG (Cappel Scientific Division, Cooper Biomedical, Inc., Malvern, PA) as the second antibody. Normal goat serum was used as the control. Fluorescence was viewed and photographed with a Zeiss photomicroscope (Morgan Instruments, Inc., Detroit, MI).
Statistics. All results in experimental groups were compared with control values using the unpaired Student's t test to examine for significant differences (P < .05).
Results
Histologic changes. The changes in glomerular morphology previously described in this model were confirmed in the present study ( Fig. 1) (I 1) . There was increased cellularity of the tuft by days 3-5 and proteinaceous material in Bowman's space by day 7, which was followed by cellular crescents (days [10] [11] [12] [13] [14] , and diffuse glomerular and interstitial fibrosis (days 21-35).
In Fig. 2 the percentage of involvement of glomeruli by acute or chronic changes in relation to time is shown. By days 6-9, 90% of glomeruli have acute inflammatory changes. At days 51-55, however, only 3% of glomeruli are inflamed as defined by increased numbers of cells or proteinaceous matrix, while 47% of glomeruli appear normal and 50% show fibrosis.
Isolation of glomeruli. Purity of the glomerular preparations for the control, and in the days-6-9, and days- [14] [15] [16] groups was 84±4%, 87±5%, and 79±3%, respectively. The glomeruli isolation procedure resulted in our obtaining prepa- Figure 1 . Masson trichrome-stained histological sections of kidney from rabbits. The dark homogeneous areas within glomeruli and vessels are the iron oxide perfused into the kidney to facilitate glomerular purification. Note the increase in number of cells per glomerulus on day 5, the formation of fibrin-containing proteinaceous material in Bowman's space on day 7, the cellular crescent and periglomerular interstitial mononuclear infiltrate on day 14, the homogeneous appearance of some glomeruli indicating replacement by collagenous matrix (blue-stained), and the loss of tubules by day 21, and the widespread fibrotic process by day 30. rations that were biased towards more normal-appearing glomeruli. This is illustrated by the results from a separate study (Eldredge, Wiggins, and Kunkel, unpublished data), where the morphologic appearance of isolated glomeruli was compared with the morphologic appearance of glomeruli in histological sections from the same animals. Glomeruli in each case were scored as normal, increased number of cells, or crescents present. The values given as the percentages oftotal number of normal, increased cells or crescentric glomeruli for isolated glomeruli/histological sections at day 4 were 16±4/8+2, 84±8/92±6, and 0/0; for day 7 they were 30±7/4+2, 42±8/46±7, and 28±3/50±9; for day 14 they were 59±10/ 14+5, 14±6/26±8, and 27±4/60±10. For day 21 > 95% of isolated glomeruli appeared normal compared with -50% in the histological sections. Therefore, we were not able to isolate representative glomeruli after day 14 of the disease model using the iron embolization technique, and even those glomeruli isolated from before day 21 were significantly biased towards more normal glomeruli. Thus, the data for isolated glomeruli must be interpreted with this bias in mind.
Collagen accumulation in glomeruli and cortex. Glomerular OH-Pro content was increased significantly by days 14-16 ( Fig. 3) flects the failure to isolate representative glomeruli on day 14 or the loss of cellular crescents from the isolated glomeruli. In spite ofthis, the OH-Pro content per glomerulus was increased by day 14.
OH-Pro content in the renal cortex (Fig. 4) was significantly increased by days 6-9 when expressed per unit DNA (0.141±0.013 gg OH-Pro/,Mg DNA vs. control 0.095±0.006 Mg Five animals per time point were used to generate the collagen synthetic rate data. The number of animals used for the collagen accumulation data is as shown in Fig. 4 (A).
fibrosis on Masson's trichrome-stained sections underestimated the increase measured biochemically at early time points. At days 14-16 when cortical OH-Pro had increased by 150%, there was only mild fibrosis histologically (Fig. 5) .
Collagen synthesis. The rate of synthesis of collagen in the cortex (Fig. 6) was significantly elevated by day 3 when expressed per dry weight (135±9 nmol proline/g dry weight, % control, P < .05), peaked around day 15 (255±24 nmol pro-
line/g dry weight, % control, P < .001), and returned to control levels by day 21 (127±9 nmol proline/g dry weight, % control, P < .05). Noncollagen protein synthesis followed a similar pattern. Collagen accumulation and rate of synthesis are directly compared in Fig. 7 . As expected, increased collagen content lagged several days behind the increase in rate of synthesis and was maintained after the rate of synthesis returned to baseline.
Patterns ofaccumulation of interstitial and type IV collagen. Control glomeruli had mesangial and capillary loop staining with anti-type IV collagen antibody. When using anti-type I/III collagen antibody some control glomeruli were negative while others showed scattered mesangial staining (Fig.  8 ). There was a progressive increase in glomerular fluorescence at days 7 and 14 with both anti-type I/III and anti-type IV. However, the patterns of staining with the two antisera differed. With anti-type IV, fluorescence was increased in the tuft by day 7 although the glomeruli architecture remained intact. By day 14 sheets of homogeneous staining were present in glomeruli and also involved the crescent and immediate periglomerular region (Figs. 8 and 9 ). Interstitial involvement was limited to brighter and apparent thickening of the tubular basement membrane (TBM). Fluorescence with anti-type I/III, on the other hand, involved both the glomerulus and interstitium. At day 7, tuft fluorescence was increased (Fig. 8) . In many glomeruli at this time there was also interstitial staining around glomeruli (not shown). At 2 wk, fluorescence in both the glomerulus and the interstitium was further increased (Fig. 8) . Interestingly, in some areas there was bright interstitial TYPE 1/111 Figure 8 . Time-course of type IV and type I/111 collagen distribution as assessed by immunofluorescence. Note that by day 7 immunofluorescence was obviously increased for both type IV and type I/III although the basic glomerular structure appeared to remain relatively intact. By day 14 glomerular architecture was grossly distorted as assessed by both type IV and I/III staining. However, the type I/III staining was much less within glomeruli than in the periglomerular and interstitial areas (see Fig. 10 ), while the type IV staining was predominantly intraglomerular. fluorescence surrounding nonstaining glomeruli (Fig. 10) , while in other areas the glomerulus was positive and the surrounding interstitium was negative (not shown).
In summary, anti-type IV staining is localized to the tuft, immediate periglomerular area, and crescent. Fluorescence with anti-type I/III may involve primarily the glomerulus, interstitium, or both.
Discussion
The pathogenesis of renal fibrosis as a consequence of acute glomerulonephritis is incompletely understood. Collagen-producing cells in the renal cortex include at least epithelial, endothelial, and mesangial cells of the glomerulus and interstitial fibroblasts. While epithelial and endothelial cells make basement membrane collagens (types IV and V) and fibroblasts make interstitial collagens (types I and III), mesangial cells can produce both classes of collagen (types I, III, IV, and V), at least in tissue culture (8, 9, 21 ). An array of chemical mediators produced by resident and infiltrating cells have been identified that may influence the rate of collagen synthesis and breakdown (2, 4, 7, 19, (22) (23) (24) (25) (26) . To better understand the regulation of renal fibrosis we studied the time-course of collagen formation in a rabbit model of crescentic nephritis.
In this model, the outcome of the acute inflammatory phase is not uniform among the glomeruli. While 90% of glomeruli are involved at day 7, 50% ultimately become histologically normal again, and 50% develop fibrosis. The local factors determining these different outcomes are not known. Fibrogenesis as defined by increased renal cortical collagen synthesis appears to be switched on and then off in the first 2 wk after anti-GBM administration. The rate of collagen synthesis is increased by day 3-4 and rises toward a maximum rate by day 7, at which time little collagen accumulation has occurred. By 14 d the synthetic rate is still high, and collagen content has significantly increased in both the glomeruli and the cortex. At 21 d, the rate of synthesis has returned towards baseline although collagen content continues to rise slowly thereafter. While such data are not available for other models of renal disease, a similar pattern was observed in a rat model of pulmonary fibrosis (17) . In both cases there is a prompt increase in collagen synthetic rate which lasts for a finite period, followed a few days later by increases in total collagen deposition. This suggests that ifthe new collagen being synthesized is associated with a rise in collagenolysis, the increase in collagenolysis must be of a smaller magnitude than the increase in synthetic rate. It is possible that the situation in the kidney may be similar to that seen in the fibrotic lung where there is a significant decrease in collagenolytic activity (down to undetectable levels) at time points greater than 1 wk (17) . In the present study, although synthetic rate returned to close to normal levels at time points greater than 14 d, there was still a CONTROL DAY 15 small (but not statistically significant) increase above control levels at these later time points. This may account for the continuing, though slight, increase in total collagen content at time points greater than 22 d.
Cell-mediated immunity may play a key role in turning the fibrogenic response on and off (2) (3) (4) . In a guinea pig model of anti-TBM interstitial nephritis, T lymphocytes early in the disease promote fibroblast proliferation and collagen production (2) . By day 18, however, T lymphocytes begin elaborating a substance that inhibits fibroblast proliferation (2) . Thus, while the regulation of fibrogenesis is complex and poorly understood, in these models there is a period of enhanced collagen production after the stimulus, which is followed by downregulation back to control levels.
When comparing histologic and biochemical methods of assessing fibrosis, it becomes apparent that Masson's trichrome staining is relatively insensitive. At 14 d, when cortical OH-Pro has increased by 150%, there is only a mild degree of fibrosis by light microscopy. Furthermore, immunofluorescent analysis showed marked distortion of glomerular architecture with sheets of material staining for type IV collagen when no such changes were seen by Masson trichrome staining. The clinical implication is that kidney biopsies showing even mild fibrosis by Masson trichrome staining may represent a significant increase in cortical collagen accumulation. This would explain in part why individuals with lupus nephritis, for example, with mild fibrosis on biopsy are at high risk for developing chronic renal failure (10) , and it raises the question of whether more sensitive indicators ofincreased collagen synthesis should be used in the assessment of renal biopsy material. On a routine basis, the use of periodic-acidSchiff stain silver methenamine, and van Gieson stains may improve sensitivity for collagen staining somewhat. However, immunofluorescence using collagen antibodies may be preferable because of its sensitivity and specificity as we have shown to exist in this study.
Previous studies have examined the distribution of interstitial and basement membrane collagens in crescentic nephritis. In a rat model ofnephrotoxic nephritis, types IV and V collagen were deposited in the tuft and crescent while interstitial collagens were identified in the tuft (type I), crescent, and interstitium (1) . In a study of human renal biopsies, those with crescentic disease showed only type IV in the glomerular tuft while type I and/or type III were identified in the crescent (6) . It was postulated that the integrity of Bowman's capsule may have determined the collagen composition of the crescent. In the present study, type IV collagen contributed to glomerular and crescentic fibrosis and to the apparent thickening of TBMs. Interstitial collagen was also found in the glomerulus and crescent but predominated in the interstitial scarring. In this study we did not examine the integrity of Bowman's capsule, so that no conclusions can be drawn regarding the relationship between the increased fluorescence for type I/III collagen and holes in Bowman's capsule. It is inter-esting that trace amounts of interstitial collagen were seen in some glomeruli of control animals. Others have reported that types I and III collagen are not seen in the normal glomerulus (1, 5, 6) . However, the results from the control glomerulus stained with monoclonal anti-type I antibody in one of these studies (1) appears to be very similar to our control anti-type I/III results, raising the question of whether some glomeruli of normal animals contain small amounts of interstitial type collagen. While this trace positivity with anti-type I/III in control glomeruli may be due to antiserum impurities or to artifact, the available data do not allow us to rule this out as a real observation. Mesangial cells have been shown to produce types I and III collagen in culture (8, 9) . This area merits further investigation to establish whether interstitial collagen in glomerular lesions results only from fibroblast infiltration or if it can originate from resident glomerular cells as well.
The potential clinical relevance of these observations can be seen by comparing these studies with our previous studies using the same model. They have shown that monocytes and activated T cells are first seen within glomeruli by day 3 (27, 28) , proteinuria begins on day 4, the urine sediment becomes abnormal on days 5-6, oliguria occurs on days 6 and 7 (29, 30) , and the serum creatinine is raised by day 7 and continues to rise through day 14 These findings cannot be directly compared with most cases of human crescentic nephritis because this model is synchronous (all glomeruli moving through the "stages" (1 1) of crescent formation together), whereas many cases ofcrescentic nephritis in man are "asynchronous" (glomeruli are at different "stages" of crescent formation at any one point in time). However, for a single glomerulus the time-course described is probably appropriate and is similar to that previously described in a rat model of crescentic glomerulonephritis (31) .
The implications for therapy are therefore that there is a window ofopportunity for therapy, but that it is short. Starting therapy must be an urgent matter where 24 h lost may count towards permanent loss of renal function. Even a small change in renal function may indicate significant collagen synthesis and accumulation. Finally, in our efforts to improve the prognosis of individuals with rapidly progressive glomerulonephritis (and other forms of inflammatory renal disease) it may be as profitable to focus on reducing the time interval between presentation and treatment (i.e., education) as it will be to develop new forms of antiinflammatory therapy.
